Altre lingue Hubei Jumpcan Pharmaceutical Co., Ltd.

Azioni

600566

CNE0000018X6

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
40,64 ^CNY	-0,81%		-6,53%	+29,30%

19/04	Hubei Jumpcan Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
09/04	Hubei Jumpcan Pharmaceutical Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	09/04
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	03/04
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	03/01
Jumpcan Pharma Registers Two New Drugs	02/11
Hubei Jumpcan Pharma’s Q3 Profit Jumps 4.8%, Revenue Falls 6%	23/10/23
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	22/10/23
Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it has received CNY 100 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd., Kunlun Capital, Zhejiang Saizhi Bole Equity Investment Management Co., Ltd, Zhongshan Zhonghui Investment Group Co.,ltd.	13/10/23
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	10/10/23
Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it expects to receive CNY 60 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd.	18/09/23
Hubei Jumpcan Pharma Registers Oral Solution to Treat ADHD	12/09/23
Hubei Jumpcan Pharma Logs Double-Digit Earnings Growth in H1 on Strong Sales, Reduced Costs; Shares Jump 5%	14/08/23
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	13/08/23
Hubei Jumpcan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	04/07/23
Hubei Jumpcan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	03/07/23
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/04/23
Hubei Jumpcan Pharma to Apply For Up to 2 Billion Yuan Loan in 2023	10/04/23
China's Weibo ups stake in Inmyshow Digital with $315 million acquisition	01/03/23
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/01/23
Rating Agency Ends Rating Hubei Jumpcan Pharmaceutical's Bonds	18/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hubei Jumpcan Pharmaceutical Co., Ltd.

Azioni

600566

CNE0000018X6

Altre lingue

Filtri